Health Technology / Projects

Second Programme of Community action in the Field of Health 2008-2013
Nightlife Empowerment and Well-being Implementation project [NEW Implementation]
1-To improve field work interventions: improving and standardizing existing interventions reducing synthetic drugs related harm, facilitating their transferability and implementation.
2- To adapt resp...
1-To improve field work interventions: improving and standardizing existing interventions reducing synthetic drugs related harm, facilitating their transferability and implementation.
2- To adapt responses to partygoers mobility: increasing harm reduction behaviors among tourist partygoers and reducing crisis situations in recreational settings.
3-To develop innovative responses adapted to youth cultures: developing individual harm reduction strategies through the use of interactive technology tools and emerging media.
4-To develop community empowerment: improving health settings and reducing harm related through community empowerment among European night clubs and events, implementing "Party+" labels within EU cities or regions and involving big summer festivals organizers in harm reduction responses.
5-To implement new projects and to enlarge the network: initiating and supporting emerging projects reducing synthetic drugs related harm in nightlife settings.
6-To improve the rapidity and quality of field responses in relation with new trends, new substances and adulterants.
Start date: 01/01/2011 - End date: 01/01/2014

Call: Promote Health (Hp-2010)
Topic: Health Technology
Second Programme of Community action in the Field of Health 2008-2013
Recreational Drugs’ European Network: an ICT prevention service addressing the use of novel compounds in vulnerable individuals [ReDNet]
The main objectives of the ReDNet Research project are:

• to design an innovative and effective ICT-based model to share knowledge and information with health/other professionals and raise awarene...
The main objectives of the ReDNet Research project are:

• to design an innovative and effective ICT-based model to share knowledge and information with health/other professionals and raise awareness of the potential harms associated with new drugs
• to design an innovative and effective ICT-based model to share knowledge and information with health and other professionals and raise awareness of the potential harms associated with new drugs
• to identify and disseminate key recommendations relevant to the development of the awareness on novel compounds initiatives across the EU
• to identify any remaining gaps in knowledge and methodological lessons learned, to inform future projects in the field of drug prevention using ICT tools

Start date: 01/04/2010 - End date: 01/07/2012

Call: Promote Health (Hp-2009)
Topic: Health Technology
3rd Health Programme (2014-2020)
Promoting Implementation of Recommendations on Policy, Information and Data for Rare Diseases [RD-ACTION]
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition...
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition leading to diagnostic delay and inappropriate management including adapted social services, poor health outcomes, social burden, limited knowledge on natural history and pathophysiology leading to an insufficient development of new therapies. The low prevalence and the specificity of RD make that a global, multi-stakeholder approach, intended to gather specific expertise and to build shared strategies is necessary to address these issues.
The general objectives of RD-Action are to:
▪ Support the further development and sustainability of the Orphanet database, the biggest global repository of information on RD
▪ Contribute to solutions to ensure an appropriate codification of RD in health information systems
▪ Continue implementation of the priorities identified in Council Recommendation 2009/C151/02 and the Commission Communication (COM 2008 679) on RD, with a view to ensuring the sustainability of the recommended priority actions and to support the work of the Commission Expert Group on Rare Diseases (CEGRD).
This JA will expand and consolidate the achievements of the former JAs on RD supported by the European Commission: the Orphanet JA and the EUCERD JA. More precisely, this proposal has the ambition to help member states to implement the recommended measures adopted or to be adopted by the CEGRD and to produce the data necessary for countries to do so. Interactions between the production of data at the Orphanet database level and the implementation of policy priorities including codification will be strengthened during this JA.RD-Action large geographical coverage is key to success as it will promote the transfer of European recommendations into national policies and the collection of information and concerns from MS to the CEGRD, thus to the European Commission.

Start date: 01/06/2015 - End date: 31/07/2018

Call: Grants for actions co-financed with Member State authorities 2014 (Joint Actions)
Topic: Health Technology